Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a body weight adjusted dose of thyroxin is
superior to treatment guided by laboratory results of thyroxin hormones in patients with
central hypothyroidism. Moreover beneficial effects of triiodthyronine supplementation are
investigated.